Allowing risky drugs for informed patients

He advocates monitored use and patient choice for high-variation drugs rather than blanket bans.

Play episode from 45:08

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!